Cargando…
Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells
With the general decline of pharmaceutical research productivity, there are concerns that many components of the drug discovery process need to be redesigned and optimized. For example, the human immortalized cell lines or animal primary cells commonly used in traditional drug screening may not fait...
Autores principales: | Xu, Xiao-hong, Zhong, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674515/ https://www.ncbi.nlm.nih.gov/pubmed/23685955 http://dx.doi.org/10.1038/aps.2013.63 |
Ejemplares similares
-
Induced pluripotent stem cells in the study of neurological diseases
por: Saporta, Mario A, et al.
Publicado: (2011) -
Current status of drug screening and disease modelling in human pluripotent stem cells
por: Rajamohan, Divya, et al.
Publicado: (2013) -
Modeling Neurological Disorders by Human Induced Pluripotent Stem Cells
por: Kunkanjanawan, Tanut, et al.
Publicado: (2011) -
Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases
por: Chang, Eun-Ah, et al.
Publicado: (2019) -
Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19
por: Nolasco, Patricia, et al.
Publicado: (2020)